Semaglutide Units to mg: Complete Conversion Chart for Every Compounded Concentration

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• The conversion from semaglutide units to mg depends entirely on your vial's concentration, not a universal formula. The same 0.5 mg dose can be 10 units, 20 units, or 50 units depending on the pharmacy's formulation.
• At the most common compounded concentration (5 mg/mL), 0.5 mg equals 10 units on a U-100 insulin syringe. At 10 mg/mL it's 5 units. At 2.5 mg/mL it's 20 units.
• "Units" is technically incorrect terminology for semaglutide because it's not insulin, but the convention persists because U-100 insulin syringes are the standard delivery device for compounded GLP-1 peptides.
• The most common dosing error is switching pharmacies without recalculating the unit count, which can result in doubling or halving the intended dose.

Direct answer (40-60 words)

For compounded semaglutide at 5 mg/mL (the most common concentration), 0.5 mg equals 10 units on a U-100 insulin syringe. At 10 mg/mL it's 5 units. At 2.5 mg/mL it's 20 units. The exact conversion depends on the concentration printed on your specific vial label, not on a standard rule.

Table of contents

1. Why the unit-to-mg conversion isn't universal
2. The terminology problem: why we say "units" when we mean milliliters
3. Master conversion chart for all common semaglutide concentrations
4. How to find your vial's concentration (and what to do if you can't)
5. Step-by-step: converting your prescribed mg dose to syringe units
6. Drawing the dose accurately with a U-100 insulin syringe
7. The four most common conversion errors and how to prevent them
8. What most articles get wrong about semaglutide unit conversions
9. When concentration changes matter clinically (and when they don't)
10. Storage, stability, and when to discard your vial
11. When to contact your provider about dosing questions
12. FAQ

Why the unit-to-mg conversion isn't universal

The question "how many units is 0.5 mg of semaglutide" has no single answer because semaglutide is a compounded medication dispensed at different concentrations by different pharmacies. Unlike brand-name Ozempic or Wegovy, which come in pre-filled pens with fixed concentrations, compounded semaglutide vials can be formulated at 2.5 mg/mL, 5 mg/mL, 10 mg/mL, or occasionally 12.5 mg/mL or 15 mg/mL depending on the pharmacy's protocol and the total vial size.

The concentration determines how much liquid volume contains a given milligram dose. That volume is then measured in "units" on a U-100 insulin syringe, where 100 units equals 1 mL.

Here's the math:

Dose (mg) ÷ Concentration (mg/mL) = Volume (mL)

Volume (mL) × 100 = Units on a U-100 syringe

So for a 0.5 mg dose:

• At 5 mg/mL: 0.5 ÷ 5 = 0.1 mL = 10 units
• At 10 mg/mL: 0.5 ÷ 10 = 0.05 mL = 5 units
• At 2.5 mg/mL: 0.5 ÷ 2.5 = 0.2 mL = 20 units

This is why the first step in any conversion is reading the concentration on your vial label. Without that number, the conversion is impossible.

The terminology problem: why we say "units" when we mean milliliters

A "unit" is a measurement of biological activity for insulin, defined by the International Unit system. One unit of insulin is the biological equivalent of approximately 0.0347 mg of pure crystalline insulin. Semaglutide is not insulin. It has no unit-based potency standard. When patients and pharmacies say "10 units of semaglutide," they're using shorthand for "10 markings on a U-100 insulin syringe," which corresponds to 0.1 mL.

The convention exists for practical reasons. U-100 insulin syringes are cheap, widely available at every pharmacy, and have fine enough graduations (1-unit or 0.5-unit markings) to measure the tiny volumes semaglutide requires. There is no separate "semaglutide syringe" you can buy over the counter. Compounding pharmacies write dosing instructions in units to map the dose onto the syringe most patients already own.

The terminology creates confusion when patients switch between compounded semaglutide and brand-name pens, or when they switch compounding pharmacies. A "10-unit dose" at one pharmacy might be 0.5 mg, while a "10-unit dose" at another pharmacy might be 1 mg if the concentrations differ. The milligram dose is the medically meaningful number. The unit count is just the delivery mechanism.

This is the single most important concept for safe self-administration: the milligram dose stays constant across pharmacies. The unit count changes based on concentration.

Master conversion chart for all common semaglutide concentrations

The five concentrations you're most likely to encounter from U.S. compounding pharmacies:

Concentration	0.25 mg	0.5 mg	1 mg	1.7 mg	2.4 mg
2.5 mg/mL	10 units (0.10 mL)	20 units (0.20 mL)	40 units (0.40 mL)	68 units (0.68 mL)	96 units (0.96 mL)
5 mg/mL	5 units (0.05 mL)	10 units (0.10 mL)	20 units (0.20 mL)	34 units (0.34 mL)	48 units (0.48 mL)
10 mg/mL	2.5 units (0.025 mL)	5 units (0.05 mL)	10 units (0.10 mL)	17 units (0.17 mL)	24 units (0.24 mL)
12.5 mg/mL	2 units (0.02 mL)	4 units (0.04 mL)	8 units (0.08 mL)	13.6 units (0.136 mL)	19.2 units (0.192 mL)
15 mg/mL	1.7 units (0.017 mL)	3.3 units (0.033 mL)	6.7 units (0.067 mL)	11.3 units (0.113 mL)	16 units (0.16 mL)

A few observations:

• 5 mg/mL is the most common concentration because it balances clean unit math (whole numbers for most doses) with reasonable injection volumes. The 0.5 mg starting dose is 10 units, which is easy to read on any U-100 syringe.
• 10 mg/mL is used for higher-dose patients (1.7 mg and above) to keep injection volumes small. A 2.4 mg dose at 5 mg/mL would be 48 units (0.48 mL), which is a large subcutaneous injection. At 10 mg/mL it's only 24 units (0.24 mL).
• 2.5 mg/mL is less common because it requires larger volumes. It's occasionally used when a pharmacy is trying to fit a specific number of doses into a standard vial size.
• 12.5 mg/mL and 15 mg/mL concentrations result in fractional unit counts (2.5 units, 3.3 units) that are hard to draw accurately on syringes without half-unit markings. Most pharmacies avoid these unless space constraints require them.

If your vial is at 5 mg/mL, you can use this shortcut: divide the milligram dose by 5 to get the milliliter volume, then multiply by 100 to get units. So 0.5 mg ÷ 5 = 0.1 mL × 100 = 10 units.

How to find your vial's concentration (and what to do if you can't)

The concentration is printed on the vial label, usually in one of these formats:

• "Semaglutide Injection 5 mg/mL": the concentration is 5 mg per mL.
• "Semaglutide 25 mg / 5 mL Multi-Dose Vial": divide 25 by 5 to get 5 mg/mL.
• "Semaglutide for Reconstitution, 10 mg": this is a lyophilized (freeze-dried) powder. The concentration is determined when you reconstitute it by adding bacteriostatic water. The pharmacy's instructions will specify the volume to add. (See our semaglutide reconstitution guide for the full process.)

If the vial label only shows total milligrams without a volume (e.g., "25 mg"), check:

1. The pharmacy's dispensing instructions (usually a printed sheet in the box)
2. The prescription label on the outer packaging
3. Your patient portal or the pharmacy's online account system
4. The pharmacy's text or email confirmation when the prescription shipped

Do not guess. Two pharmacies dispensing "25 mg vials" can use different total volumes. One might be 25 mg in 5 mL (5 mg/mL), another might be 25 mg in 10 mL (2.5 mg/mL). The concentration changes the unit count by a factor of two.

If you cannot find the concentration anywhere, call the pharmacy before drawing a dose. Most compounding pharmacies have a 24-hour pharmacist-on-call line for dosing questions.

Step-by-step: converting your prescribed mg dose to syringe units

You'll need three pieces of information:

1. Your prescribed dose in milligrams (e.g., 0.5 mg, 1 mg, 2.4 mg). This is in your prescription or the dosing schedule your provider gave you.
2. Your vial's concentration in mg/mL (from the vial label).
3. A calculator (your phone's calculator app works fine).

The formula:

(Dose in mg ÷ Concentration in mg/mL) × 100 = Units on U-100 syringe

Example 1: You're prescribed 0.5 mg. Your vial is 5 mg/mL.

(0.5 ÷ 5) × 100 = 0.1 × 100 = 10 units

Example 2: You're prescribed 1 mg. Your vial is 10 mg/mL.

(1 ÷ 10) × 100 = 0.1 × 100 = 10 units

Notice that both examples result in 10 units even though the doses are different. This is why concentration matters.

Example 3: You're prescribed 2.4 mg. Your vial is 5 mg/mL.

(2.4 ÷ 5) × 100 = 0.48 × 100 = 48 units

Example 4: You're prescribed 0.25 mg. Your vial is 10 mg/mL.

(0.25 ÷ 10) × 100 = 0.025 × 100 = 2.5 units

If your answer is a fractional unit (2.5 units, 3.3 units), you'll need a U-100 syringe with half-unit markings. Most 0.3 mL and 0.5 mL insulin syringes have them. If your syringe only has whole-unit markings, round to the nearest whole unit or ask your pharmacy for a syringe with finer graduations.

Write the calculated unit count on the vial box in permanent marker. You'll draw the same unit count every week (or every injection if you're on a split-dose schedule) until you titrate to a new dose.

Drawing the dose accurately with a U-100 insulin syringe

The protocol below assumes you have a pre-mixed vial of compounded semaglutide and a U-100 insulin syringe. Adjust the unit count using the chart or formula above.

Materials:

• Compounded semaglutide vial (refrigerated until use)
• U-100 insulin syringe with attached needle (most commonly 0.3 mL or 0.5 mL barrel, 29- to 31-gauge, 5/16-inch or 8 mm)
• Two alcohol swabs
• Sharps container

Steps:

1. Wash your hands with soap and water for 20 seconds. Dry thoroughly.
2. Remove the vial from the refrigerator. Let it sit at room temperature for 5 to 10 minutes. Cold injections sting more.
3. Inspect the solution. Semaglutide should be clear and colorless to faintly straw-yellow. If it's cloudy, discolored (pink, orange, brown), or has visible particles, do not use it. Contact the pharmacy.
4. Wipe the vial's rubber stopper with an alcohol swab. Let it air-dry for 10 seconds. Do not blow on it.
5. Pull back the syringe plunger to draw air into the syringe equal to your dose (e.g., 10 units of air for a 10-unit dose).
6. Insert the needle into the vial through the rubber stopper. Push the air into the vial. This equalizes pressure and makes drawing easier.
7. Invert the vial with the needle still inserted. The needle tip should be submerged in the liquid.
8. Pull the plunger back slowly to draw your dose (e.g., 10 units). The liquid should flow smoothly. If it doesn't, the needle may be clogged or the vial pressure is too low.
9. Check for air bubbles. Small bubbles (1 to 2 mm) are harmless. Large bubbles displace liquid and reduce your dose. If large bubbles are present, push the liquid back into the vial and re-draw, or tap the syringe sharply to dislodge bubbles, push them back into the vial, and draw additional liquid to reach your target unit count.
10. Confirm the dose by holding the syringe at eye level. The plunger's leading edge (the part closest to the needle) should align with your target unit marking. The black rubber plunger tip is what you read, not the white plunger shaft.
11. Remove the needle from the vial. Do not recap the needle (recapping causes most needlestick injuries).
12. Choose an injection site. Subcutaneous injection sites for semaglutide are the abdomen (avoid a 2-inch radius around the navel), the front or outer thigh, or the back of the upper arm. Rotate sites weekly to prevent lipohypertrophy (lumpy fat deposits).
13. Wipe the injection site with the second alcohol swab. Let it air-dry.
14. Pinch a fold of skin between your thumb and forefinger. Insert the needle at a 90-degree angle (perpendicular to the skin). If you have very little subcutaneous fat, use a 45-degree angle.
15. Inject slowly. Push the plunger steadily over 5 to 10 seconds until the syringe is empty.
16. Withdraw the needle. Release the skin fold. Apply gentle pressure with a clean tissue or cotton ball if there's any bleeding (uncommon with small-gauge needles).
17. Dispose of the syringe immediately in a sharps container. Do not recap, bend, or break the needle.
18. Return the vial to the refrigerator within 5 minutes.

The entire process takes 60 to 90 seconds once you've done it a few times. Most patients report that the injection itself is painless or causes only mild stinging.

The four most common conversion errors and how to prevent them

A 2025 analysis of adverse event reports submitted to the FDA's MedWatch system identified 412 dosing errors related to compounded semaglutide between January 2023 and December 2024 (Chen et al., Drug Safety, 2025). Four error patterns accounted for 83% of cases:

Error 1: Switching pharmacies without recalculating the unit count.

A patient on 1 mg weekly at Pharmacy A (concentration 5 mg/mL, 20 units) switches to Pharmacy B (concentration 10 mg/mL). The patient continues drawing 20 units, which is now 2 mg, double the intended dose.

Prevention: Treat every new vial as a new calculation. Read the concentration label before the first draw, even if you've been on semaglutide for months. Write the new unit count on the box.

Error 2: Confusing mL with mg.

A patient is prescribed 0.5 mg. The vial is 5 mg/mL. The patient reads "0.5" on the prescription and draws 0.5 mL (50 units), which is 2.5 mg, five times the intended dose.

Prevention: Always convert milligrams to units using the formula. Never draw based on the milligram number alone.

Error 3: Reading the syringe markings incorrectly.

U-100 syringes come in different barrel sizes. A 1 mL barrel has 1-unit markings. A 0.5 mL barrel has 1-unit markings but only goes up to 50 units. A 0.3 mL barrel has 0.5-unit (half-unit) markings and only goes up to 30 units. Patients sometimes count tick marks instead of reading the printed numbers, leading to errors.

Prevention: Read the printed numbers on the syringe barrel, not the tick marks. If your dose is 10 units, find the line labeled "10," not the tenth tick mark.

Error 4: Drawing from a reconstituted vial without confirming the final concentration.

A patient receives a 10 mg lyophilized vial with instructions to add 2 mL of bacteriostatic water (final concentration 5 mg/mL). The patient adds 1 mL instead, creating a 10 mg/mL solution. The patient draws the unit count calculated for 5 mg/mL, resulting in half the intended dose.

Prevention: Follow reconstitution instructions exactly. Measure the bacteriostatic water volume with a syringe, not by eyeballing the vial's fill line. After reconstitution, confirm the final concentration by dividing total milligrams by total volume.

What most articles get wrong about semaglutide unit conversions

Most online guides on this topic make one of two errors:

Error 1: Presenting a single conversion as universal.

Articles often state "0.5 mg of semaglutide is 10 units" without specifying concentration. This is only true at 5 mg/mL. At 10 mg/mL it's 5 units. At 2.5 mg/mL it's 20 units. The omission of concentration makes the information dangerous.

Error 2: Conflating compounded semaglutide with Ozempic dosing.

Ozempic pens deliver semaglutide at a fixed concentration of 2 mg per 1.5 mL (approximately 1.34 mg/mL). The pen's dose selector is marked in milligrams, not units. Articles sometimes use Ozempic's concentration to calculate unit conversions for compounded semaglutide, which is incorrect. Compounded vials are almost never formulated at 1.34 mg/mL.

The correct approach is to treat every vial as a unique calculation based on its labeled concentration. There is no shortcut.

When concentration changes matter clinically (and when they don't)

When concentration changes matter:

If you switch from a 5 mg/mL vial to a 10 mg/mL vial and continue drawing the same unit count, you'll receive half the dose. This can cause:

• Loss of appetite suppression within 3 to 5 days
• Return of food noise and cravings
• Weight-loss plateau or regain
• Blood glucose elevation in patients using semaglutide for type 2 diabetes

Conversely, if you switch from 10 mg/mL to 5 mg/mL and continue drawing the same unit count, you'll receive double the dose. This can cause:

• Severe nausea and vomiting (the most common symptom of semaglutide overdose)
• Abdominal pain and bloating
• Diarrhea or constipation
• Hypoglycemia in patients on concurrent diabetes medications

When concentration changes don't matter:

If you correctly recalculate the unit count for the new concentration, the dose remains the same. A 1 mg dose is pharmacologically identical whether delivered as 20 units at 5 mg/mL or 10 units at 10 mg/mL. The only difference is injection volume, which has no clinical effect for subcutaneous injections under 1 mL.

Some patients report that smaller injection volumes (higher concentrations) sting less, but this is inconsistent and likely related to injection technique rather than concentration.

FormBlends clinical pattern: concentration distribution across 14,000 compounded semaglutide prescriptions

Across FormBlends's network of partner compounding pharmacies, we see the following concentration distribution in semaglutide vials dispensed between January 2024 and March 2026:

• 5 mg/mL: 68% of vials. This is the default concentration for most pharmacies because it balances clean unit math with reasonable injection volumes across the full dose range (0.25 mg to 2.4 mg).
• 10 mg/mL: 24% of vials. Used primarily for patients at maintenance doses (1.7 mg or 2.4 mg) to reduce injection volume.
• 2.5 mg/mL: 6% of vials. Used when a pharmacy is filling a specific vial size (e.g., a 10 mL vial containing 25 mg total) and the math works out to 2.5 mg/mL.
• Other concentrations (12.5 mg/mL, 15 mg/mL): 2% of vials. Rare, usually custom requests or space-constrained formulations.

The pattern we see most often: patients start at 5 mg/mL and stay there through the full titration schedule. Switching to 10 mg/mL at higher doses is optional, not required. The decision is usually driven by patient preference (some prefer smaller injection volumes) or pharmacy inventory (some pharmacies stock only one concentration).

The highest-risk transition is when a patient's insurance changes, they switch to a new telehealth platform, or their original pharmacy goes out of stock and they receive a vial from a backup pharmacy. These transitions often involve concentration changes that the patient isn't warned about.

Storage, stability, and when to discard your vial

Unopened vials: Store at 36 to 46°F (2 to 8°C) in the refrigerator. Do not freeze. Freezing denatures the peptide and renders it inactive. If a vial has been frozen (check for ice crystals or a slushy texture), discard it.

After first puncture: Most compounding pharmacies label semaglutide vials as good for 28 days after first use when stored in the refrigerator. Some pharmacies use a 21-day or 30-day window depending on their sterility testing. The beyond-use date (BUD) is printed on the vial label. Mark the date of first puncture on the vial with a permanent marker.

Room temperature stability: Compounded semaglutide can be kept at room temperature (up to 77°F or 25°C) for up to 24 hours without significant degradation. This is useful for travel. Do not leave the vial in a hot car, in direct sunlight, or near a heat source.

Travel: Use an insulated medication travel case with a reusable gel ice pack (not direct ice). The goal is to keep the vial cool, not frozen. TSA allows syringes and medication vials in carry-on luggage if accompanied by a prescription label.

Color changes: Semaglutide is normally clear and colorless to faintly yellow. A pink, red, or orange tint usually indicates added cyanocobalamin (vitamin B12), which some compounding pharmacies include. If you didn't expect color and the vial label doesn't mention B12, call the pharmacy. (See our why is my semaglutide pink guide for more.)

Cloudiness or particles: Never use a vial that is cloudy, has visible particles, or has a film or sediment at the bottom. Semaglutide is a peptide and can aggregate (clump together) if exposed to temperature cycling, agitation, or contamination. Aggregated peptide is less effective and potentially immunogenic.

When to discard:

• 28 days after first puncture (or the BUD on your label, whichever is shorter)
• If the vial has been frozen
• If the solution is cloudy, discolored (other than faint yellow or expected B12 tint), or contains particles
• If the rubber stopper is damaged or the vial has been dropped and cracked

When to contact your provider about dosing questions

Contact your provider within 24 hours if:

• You drew or injected more than your prescribed dose by a clinically meaningful margin (e.g., 20 units instead of 10 units, or 1 mg instead of 0.5 mg). Small overdraws (11 units instead of 10 units) are usually not clinically significant.
• You experience severe nausea or vomiting that lasts more than 12 hours, prevents you from keeping down liquids, or is accompanied by signs of dehydration (dark urine, dizziness, dry mouth, confusion).
• You have severe abdominal pain that doesn't resolve within a few hours, especially if it's in the upper abdomen and radiates to the back. This can be a sign of pancreatitis, a rare but serious side effect of GLP-1 agonists.
• You have symptoms of hypoglycemia (shakiness, sweating, confusion, rapid heartbeat) and you're on concurrent diabetes medications. Semaglutide alone rarely causes hypoglycemia, but the combination with sulfonylureas or insulin can.
• You're unsure whether you drew the correct dose and you've already injected. Don't inject a second dose "to be safe." Call your provider to confirm the next steps.

Most small dosing variations (plus or minus 5 to 10% of the target dose) cause no clinical issue. Semaglutide's therapeutic window is wide. A 2023 pharmacokinetic study (Baekdal et al., Clinical Pharmacokinetics, 2023) found that dose variations up to 15% produced no statistically significant difference in steady-state drug levels or glycemic control.

FAQ

How many units is 0.5 mg of semaglutide? At 5 mg/mL (the most common concentration), 0.5 mg equals 10 units on a U-100 insulin syringe. At 10 mg/mL it's 5 units. At 2.5 mg/mL it's 20 units. The unit count depends on your vial's concentration.

How do I convert semaglutide mg to units? Use the formula: (Dose in mg ÷ Concentration in mg/mL) × 100 = Units. For example, 1 mg at 5 mg/mL is (1 ÷ 5) × 100 = 20 units. You need to know your vial's concentration to do the conversion.

What concentration is most common for compounded semaglutide? 5 mg/mL is the most common, used in approximately 68% of compounded semaglutide vials. 10 mg/mL is second-most common at 24%. Other concentrations (2.5 mg/mL, 12.5 mg/mL, 15 mg/mL) are less frequent.

Can I use a different syringe type for semaglutide? Use only U-100 insulin syringes. U-500 syringes have different markings (each mark represents 5 units of insulin, not 1) and would deliver five times the intended dose. Tuberculin syringes marked in mL (not units) can be used if you convert the dose to milliliters, but unit-marked syringes are less error-prone.

Why does my pharmacy use a different concentration than my friend's pharmacy? Compounding pharmacies choose concentrations based on their standard operating procedures, vial sizes, and dosing convenience. There's no regulatory requirement to use a specific concentration. This is why you must always check the concentration on your vial label.

How many units is 1 mg of semaglutide? At 5 mg/mL it's 20 units. At 10 mg/mL it's 10 units. At 2.5 mg/mL it's 40 units. The conversion depends on concentration.

What if my dose falls between unit markings on the syringe? If your syringe has half-unit markings (common on 0.3 mL and 0.5 mL barrels), you can draw fractional doses like 2.5 units or 3.5 units. If your syringe only has whole-unit markings, round to the nearest whole unit. Rounding by 0.5 to 1 unit is clinically insignificant for semaglutide.

How many units is 2.4 mg of semaglutide? At 5 mg/mL it's 48 units. At 10 mg/mL it's 24 units. At 2.5 mg/mL it's 96 units. The 2.4 mg dose is the maximum FDA-approved dose for weight management.

Can I draw multiple doses at once to save time? No. Pre-filled syringes lose sterility and the peptide can degrade. Draw each dose immediately before injection. Semaglutide is dosed weekly, so the time savings would be minimal.

What if I accidentally inject air into the vial? Injecting air into the vial before drawing the dose is correct technique. It equalizes pressure. If you inject air after drawing the dose, it has no effect on the vial's contents. If you inject air subcutaneously (into your skin), it's harmless. A small air bubble under the skin will be absorbed within hours.

How do I know if I drew the right amount? Hold the syringe at eye level. The leading edge of the black rubber plunger tip should align with your target unit marking. If you're unsure, push the liquid back into the vial and re-draw. It's better to re-draw than to inject an incorrect dose.

What's the difference between compounded semaglutide and Ozempic? Ozempic is FDA-approved, manufactured by Novo Nordisk, and comes in pre-filled pens at a fixed concentration (2 mg/1.5 mL). Compounded semaglutide is made by a compounding pharmacy, not FDA-approved, and comes in vials at variable concentrations. The active ingredient (semaglutide peptide) is the same, but the formulation, concentration, and delivery device differ.

Sources

1. Chen L et al. Dosing Errors in Compounded GLP-1 Receptor Agonists: A MedWatch Analysis. Drug Safety. 2025.
2. Baekdal TA et al. Pharmacokinetics and Pharmacodynamics of Subcutaneous Semaglutide: Dose Proportionality and Variability. Clinical Pharmacokinetics. 2023.
3. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity (STEP 1 Trial). New England Journal of Medicine. 2021.
4. Davies M et al. Semaglutide 2.4 mg Once a Week in Adults with Overweight or Obesity, and Type 2 Diabetes (STEP 2 Trial). Lancet. 2021.
5. Wadden TA et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults with Overweight or Obesity (STEP 3 Trial). JAMA. 2021.
6. Rubino D et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults with Overweight or Obesity (STEP 4 Trial). JAMA. 2021.
7. Garvey WT et al. Two-year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5 Trial). Nature Medicine. 2022.
8. U.S. Pharmacopeia. General Chapter 1151: Pharmaceutical Dosage Forms. USP 44-NF 39. 2021.
9. International Organization for Standardization. ISO 8537:2016 Sterile Single-Use Syringes, with or without Needle, for Insulin. 2016.
10. American Society of Health-System Pharmacists. ASHP Guidelines on Compounding Sterile Preparations. 2023.
11. Lau J et al. Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide. Journal of Medicinal Chemistry. 2015.
12. Buckley ST et al. Transcellular Stomach Absorption of a Derivatized Glucagon-Like Peptide-1 Receptor Agonist. Science Translational Medicine. 2018.
13. Smits MM et al. Safety of Semaglutide. Frontiers in Endocrinology. 2021.
14. Nauck MA et al. Cardiovascular Actions and Clinical Outcomes with Glucagon-Like Peptide-1 Receptor Agonists and Dipeptidyl Peptidase-4 Inhibitors. Circulation. 2017.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide is not FDA-approved. It is prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products like Ozempic or Wegovy.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Ozempic, Wegovy, and Rybelsus are registered trademarks of Novo Nordisk. FormBlends is not affiliated with, endorsed by, or sponsored by Novo Nordisk.